Background: The prevalence and predisposing factors of asymptomatic sensitization
to 17% in the late 90's. 5 A recent prospective study assessing the outcome of deliberate sting challenges, however, did not confirm an increased risk in asymptomatically sensitized subjects when compared to the general population. 6 The term "marker allergen" refers to components indicative of genuine sensitization to a given venom. 7 IgE testing targeting single venom marker allergens was recently introduced for routine diagnostic assessment of Hymenoptera venom-allergic patients: 2, 3 Up to 90%
of patients allergic to Vespula venom (VV) are considered to be sensitized to rVes v 5 8, 9 and just under 60% to rVes v 1. 9 The use of a diagnostic cut-off of 0.10 kU A /L instead of the traditional threshold of 0.35 kU A /L has been proposed to further increase diagnostic sensitivity in patients with low total IgE levels and/or mastocytosis. 10 While sensitization to rApi m 1 is detectable in less than 80% of bee venom (BV)-allergic patients, depending on the test system used, 8, 11, 12 specific IgE testing targeting additional BV allergens has been proposed to increase diagnostic sensitivity. 
| ME TH ODS

| Participants
Subjects were eligible for inclusion if they were at least 18 years old, able to consent and did not have a history of sting-induced anaphylactic reactions. The participants were recruited from a group of dermatologic patients who presented to our clinic between August 2014 and June 2016 for the diagnosis and/or treatment of a variety of cutaneous diseases including autoimmune, inflammatory, and malignant conditions. Written informed consent was obtained from all participants. The study was approved by the ethics committee of the Medical Faculty Würzburg.
| Questionnaire
A structured questionnaire was used to collect information on the participants' age and sex, history of atopic diseases (atopic dermatitis, allergic rhinoconjunctivitis and/or allergic asthma), and information on previous Hymenoptera stings (number of stings, time interval to last sting, history of large local or anaphylactic sting reactions). Large local reactions were defined to exceed 10 cm in diameter and to persist for more than 24 hours. 14 All questionnaires were completed with the help of trained medical staff. Subjects reporting anaphylactic sting reactions were excluded from evaluation.
| Laboratory tests
Serum total IgE and allergen-specific IgE levels were measured using 
| Statistics
Statistical analyses were performed with SPSS version 24 for Windows (SPSS Inc., Chicago, IL). Interval-scaled data are presented as median and interquartile range (IQR). Ordinally and categorically scaled data are reported as absolute and relative frequencies. Univariate and multivariate binary logistic regression analyses were performed to assess several predictor variables with regard to the prevalence of VV marker allergen-specific sensitization. All tests were 2-tailed, and P-values < 0.05 were considered statistically significant. A sample size calculation was performed prior to the initiation of the study. Assuming sensitization rates of 25%, the sample size was set at n = 500 in order to permit evaluation of up to eight parameters in a multivariate logistic regression model.
| RESULTS
| Study cohort
Of 502 subjects screened for study inclusion, six were retrospectively excluded due to a history of anaphylactic sting reactions, a further five because information on previous sting reactions was inconclusive or missing. One serum sample could not be analysed due to lipaemia, resulting in a total of 490 questionnaires and corresponding sera available for evaluation. Characteristics of the total study cohort are summarized in 
| Overall sensitization rates
Given a cut-off of 0.35 kU A /L, 138 (28.2%) participants were sensitized to VV and 135 (27.6%) were sensitized to at least one VV marker allergen (rVes v 5 and/or rVes v 1). Sensitization rates to BV and rApi m 1 were 13.9% (n = 68) and 3.5% (n = 17), respectively. Fortysix (9.4%) individuals were double-sensitized to BV and VV. Respective sensitization rates at cut-off levels of 0.10 kU A /L are depicted in Figure 1 . Of the 72 participants who did not report any previous (10.9%) were sensitized to neither. Of these five participants, two were sensitized to CCD while no target allergen was identified for the remaining three. Double positivity to both venoms and CCDdirected sensitization were clearly associated (P < 0.001, chi-squared test, Table 2 ).
| Predisposing factors for marker allergen-specific sensitization
In a preliminary analysis (univariate binary logistic regression, data not shown), a number of baseline parameters were identified to be potentially associated with sensitization to VV marker allergens: atopic conditions, history of Hymenoptera stings within the last 10 years, history of large local reactions, total IgE values exceeding 100 kU/L, concurrent sensitization to airborne allergens, and CCDspecific sensitization. venom is considered to be required if cross-reactivity to the other is due to partial sequence identity of protein allergens or to CCD. Marker allergen-based, "genuine" double sensitization, on the other hand, has been equated to double-allergy requiring venom immunotherapy with both venoms. [15] [16] [17] [18] [19] This hypothesis has been critically questioned by some authors 20 and stands in some contrast to the observation that most subjects with hitherto asymptomatic sensitization to nonglycosylated recombinant Hymenoptera venom allergens tolerate deliberate sting challenges with the respective insect. 6, 21 A recent study based on a cross-sectional population survey likewise suggests that sensitization to Hymenoptera venom marker allergens is common in the general population, whereas its clinical relevance might be low. 22 Other than in the study by 
| High sensitization rates, but low specific/total
IgE ratios in adults without history of sting-induced anaphylaxis
Our BV and VV-specific sensitization rates at cut-off levels of 0.35 kU A /L (13.9% and 28.2%, respectively, Figure 1 ) fell within the broad range of previously published data. 4, 22, [24] [25] [26] [27] The lowering of cut-off levels to 0.10 kU A /L has been suggested to permit an increase in sensitivity, 10 but is likely to impede the specificity of IgE testing. As the latter also depends on total IgE levels, 4 specific/total IgE ratios have been established for the assessment of allergic disease due to food, inhalative allergens, and drugs, 28, 29 and have been proposed to be taken into account for the diagnosis of BV allergy. antigens other than rVes v 1 or rVes v 5. 13 Of note, there was a relatively low rate of CCD-directed sensitization among VV-reactive subjects (13.0%) which is consistent with previous data showing that asymptomatic monosensitization to Hymenoptera venoms is not typically associated with CCD-directed sensitization. 4 Only 64.7% of BV-reactive subjects ( Figure 3B ) were sensitized to one or several of the commercially available BV allergens. Our findings thus demonstrate a comparatively low sensitivity of IgE testing targeting recombinant BV components in BV-sensitized adults without sting-induced anaphylaxis even if the extended panel of commercially available BV allergens was used. This is in accordance with recent observations in patients with clinically relevant BV allergy. 11 The observation of a higher rate of CCD-directed sensitization among BV-compared to VV-reactive subjects is likely to be related to a greater overlap with the double-sensitized group (see below) and might be attributed to a stronger glycosylation of BV allergens. 
| Serological double reactivity to BV-and VV marker allergens is frequent
Our observation of a highly significant association between sensitization to CCD and dual reactivity to both BV and VV (P < 0.001, Table 2 ) is in accordance with ample data from previous publications, 4, 9, 15, 17, 22, 31 and CCD-mediated sensitization is generally considered to be associated with asymptomatic IgE reactivity to multiple allergens. 32, 33 Sensitization to marker allergens of both species was nonetheless detectable in the majority of our double-sensitized participants (Figure 4) , and componentresolved diagnostics enabled the identification of exclusive sensitization to either BV allergens or VV allergens in only 32.6% of cases. Our data thus demonstrate that serological double sensitization remains a diagnostic dilemma which has not been fully (Table 3) .
| Recent Hymenoptera stings
Of note, the lifetime prevalence of stings including incidents in the distant past was not associated with sensitization to VV marker allergens (univariate logistic regression, data not shown). In accordance with previous studies on the natural course of sensitization to Hymenoptera venoms, our data suggest that sensitization to VV marker allergens peaks shortly after the sting, subsequently wanes, and may fall below the limits of detection within a couple of years. 
| Large local reactions upon previous
Hymenoptera stings
In accordance with our current data, previous studies described sensitization to Hymenoptera venoms as a cause of large local reactions, 6, 25, 34 which could, however, not be traced back to a molecular level. Our data indicate that, rather than Ves v 5, Ves v 1 might be the main target allergen in large local reactors.
| Total IgE elevation
A relation between total IgE levels and asymptomatic sensitization to Hymenoptera venoms has been recognized in earlier studies. 4, 27 While our study indicates that this also applies to single venom marker allergens, it provides further evidence that total IgE values invariably need to be taken into account for any interpretation of allergen-specific IgE.
| Sensitization to CCD
Other than native venom preparations, recombinant allergens used in the ImmunoCAP ™ system are not glycosylated. The observed association between sensitization to CCD and reactivity to rVes v 5 and/or rVes v 1 is thus surprising and somewhat alarming. Our current findings, however, are consistent with the observation of a higher frequency of sensitization to recombinant marker allergens of both species in patients with double positivity to BV and VV plus concurrent sensitization to CCD compared to those without. 8 An explanation was recently presented by Hemmer et al. 33 CCD-positive sera showed IgE binding to blank ImmunoCAPs as well as to ImmunoCAPs carrying recombinant inhalative or venom allergens. Unspecific binding could be completely blocked by serum preincubation with a CCD inhibitor 32 and was traced back to varying amounts of CCD on the cellulose allergen carrier. CCD-related false-positive test results might thus be a cause of the relatively high frequency of marker allergen-directed reactivity observed in our double-sensitized participants, especially if cut-off values were lowered to 0.10 kU A /L (Table 3) . Despite these considerations, it was shown by other methods (eg, basophil activation test) that a sensitization to recombinant marker allergens of both species in patients with double positivity to BV and VV together with a sensitization to CCD exists. 
